CV Sciences Inc. (CVSI) Responds to Class Action Lawsuit

Share this Article

​LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company that alleges violations of federal securities laws.  The Company disputes the allegations in the complaint and will vigorously defend this lawsuit.

​“The conclusions in the complaint and in the ‘report’ by Citron Research are outright false, and demonstrate either an ignorance, a disregard, or both, of the basics of patent prosecution,” stated Mr. Dowling.  “A ‘final rejection’ in the context of patent prosecution is anything but final.  It by no means indicates that the applicant has failed in its efforts to obtain an issued patent.” We will continue to prosecute the ‘617 Application and plan to file and prosecute several more applications related to the inventions described in the ‘617 Application.”


Add a Comment

Your email address will not be published. Required fields are marked *